Skip to main content
Top
Published in: Cardiovascular Intervention and Therapeutics 4/2021

01-10-2021 | Intravascular Ultrasound | Images in Cardiovascular Intervention

Successful Fogarty venous thrombectomy without a skin incision for organized thrombi caused by May-Thurner syndrome

Authors: Yuji Nishimoto, Masanao Toma, Yuta Matsui, Rei Fukuhara, Tadashi Miyamoto, Yukihito Sato

Published in: Cardiovascular Intervention and Therapeutics | Issue 4/2021

Login to get access

Excerpt

A 69-year-old woman without a history of venous thromboembolism was admitted to our hospital with a chief compliant of a red swollen left lower extremity that persisted for 3 months. Doppler ultrasound revealed occlusive thrombi from the left popliteal vein to the common iliac vein and computed tomographic venography revealed suspected iliac vein compression syndrome (May-Thurner syndrome; MTS). Diagnosed as subacute deep vein thrombosis (DVT), she received oral anticoagulation with rivaroxaban, an oral factor Xa inhibitor, 15 mg twice daily for 5 days (Day 0–4). Given that the degree of the symptoms was remarkable, suggesting the presence of insufficient collateral flow and acute-on-chronic DVT factors, we decided to perform a catheter-directed thrombolysis (CDT). After placement of an inferior vena cava filter, intravascular ultrasound (IVUS) confirmed the diagnosis of MTS. CDT via the left saphenous vein (Day 4) and that via the left popliteal vein 3 days later (Day 7) using an infusion catheter (5-Fr Fountain catheter, Merit Medical, South Jordan, Utah) with a continuous infusion of urokinase (240,000 IU per day) and oral anticoagulation with rivaroxaban (15 mg once daily) did not improve her symptoms sufficiently. Although venography (Day 11) confirmed sufficient inflow from the left femoral vein, venography and IVUS revealed a lot of organized thrombi in the iliac vein, and a subsequent venous thrombectomy was performed (Fig. 1a). A 22-Fr DrySeal sheath (W. L. Gore, Flagstaff, Arizona) was placed in the left femoral vein without a skin incision, and a successful thrombectomy using a 4-Fr Fogarty balloon catheter (Edwards Lifesciences, Irvine, California) was performed (Fig. 1b, c). Despite being on anticoagulation therapy, complete hemostasis was achieved by manual compression for 20 min after removing the sheath, followed by one stitch suture and 5-h gauze compression. There were no access-site complications such as an arteriovenous fistula. After oral anticoagulation with rivaroxaban (15 mg twice daily) for 3 days, venography (Day 14) revealed the successful revascularization of the iliac vein without a stent implantation (Fig. 1d), and the filter was removed. Her symptoms were completely relieved without any recurrence within 30-days.
Literature
1.
go back to reference Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377:2240–52.CrossRef Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377:2240–52.CrossRef
2.
go back to reference Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, et al. Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry. Heart Vessels. 2019;34:669–77.CrossRef Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, et al. Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry. Heart Vessels. 2019;34:669–77.CrossRef
Metadata
Title
Successful Fogarty venous thrombectomy without a skin incision for organized thrombi caused by May-Thurner syndrome
Authors
Yuji Nishimoto
Masanao Toma
Yuta Matsui
Rei Fukuhara
Tadashi Miyamoto
Yukihito Sato
Publication date
01-10-2021
Publisher
Springer Singapore
Published in
Cardiovascular Intervention and Therapeutics / Issue 4/2021
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-020-00703-0

Other articles of this Issue 4/2021

Cardiovascular Intervention and Therapeutics 4/2021 Go to the issue